Hypertension in Pregnancy and Postpartum: Current Standards and Opportunities to Improve Care
Abstract
Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur, leading to preeclampsia and gestational hypertension. The diagnosis and effective management of hypertension during pregnancy is essential to mitigate maternal risks, such as acute kidney injury, stroke, and heart failure, while balancing potential fetal risks, such as growth restriction and preterm birth due to altered uteroplacental perfusion. In the postpartum period, innovative and multidisciplinary care solutions that include postpartum maternal health clinics can help optimize short- and long-term care through enhanced BP management, screening of cardiovascular risk factors, and discussion of lifestyle modifications for cardiovascular disease prevention. As an adjunct to or distinct from postpartum clinics, home BP monitoring programs have been shown to improve BP ascertainment across diverse populations and to lower BP in the months after delivery. Because of concerns about pregnant patients being a vulnerable population for research, there is little evidence from trials examining the diagnosis and treatment of hypertension in pregnant and postpartum individuals. As a result, national and international guidelines differ in their recommendations, and more studies are needed to bolster future guidelines and establish best practices to achieve optimal cardiovascular health during and after pregnancy. Future research should focus on refining treatment thresholds and optimal BP range peripartum and postpartum and evaluating interventions to improve postpartum and long-term maternal cardiovascular outcomes that would advance evidence-based care and improve outcomes worldwide for people with hypertensive disorders of pregnancy.
Article Details
Authors (20)
Malamo Countouris
UPMC, PIttsburgh, Pennsylvania, United States
Zainab Mahmoud
Washington University in St. Louis, St. Louis, MO (M.D.H., A.V., Z.M.).
Jordana B. Cohen
Daniela Crousillat
Department of Medicineand Obstetrics and Gynecology, Division of Cardiovascular Sciences, University of South Florida Morsani College of Medicine, Tampa General Hospital Heart and Vascular Institute (D.C.).
Afshan B. Hameed
Colleen M. Harrington
Department of Medicine, Division of Cardiology, Women’s Heart Health Program, Massachusetts General Hospital, Boston (C.M.H., M.C.H., A.S.).
Alisse Hauspurg
Michael C. Honigberg
Jennifer Lewey
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Kathryn Lindley
Vanderbilt University, Nashville, Tennessee, United States
Megan M. McLaughlin
Neha Sachdev
American Medical Association, Chicago, IL (N.S.).
Amy Sarma
Department of Medicine, Division of Cardiology, Women’s Heart Health Program, Massachusetts General Hospital, Boston (C.M.H., M.C.H., A.S.).
Kayle Shapero
Brown University Health Cardiovascular Institute (K.S.), Alpert Medical School of Brown University, Providence, RI.
Rachel Sinkey
UAB, Birmingham, Alabama, United States
Alan Tita
University of Alabama at Birmingham, Birmingham, Alabama, United States
Kristen E. Wong
Department of Medicine, Division of Cardiology, Washington University in St Louis, MO (Z.M., K.E.W.).
Eugene Yang
Leslie Cho
Natalie A. Bello